The American Society of Neuroradiology funds imaging-based research that advance our understanding of Alzheimer’s disease, help identify new treatment strategies, provide information to improve care for people with dementia, and further our knowledge of brain health and disease prevention. Our awards support investigators at every professional stage and always include categories specifically designed to help talented young scientists establish careers in Alzheimer’s imaging research.
Congratulations to the following recipients of the ASNR Alzheimer’s Imaging Research Program grants.
Use of AI for intermodality conversion of brain MR to PET for diagnosis of AD, MCI, and aging normals
[18F] PI-2620 PET in Primary Progressive Aphasia
Exploring the relationship between tau deposition and neurovascular health in Alzheimer’s disease
Evaluation of [F18]NOS as a Novel PET Radiotracer for Neuroinflammation in Alzheimer’s Disease
Amount Funded: $250,000.00
Iron-Based Neuroinflammation: A New Window to AD Pathology
Amount Funded: $99,460.00
Diffusion MR Imaging based Edge Density Connectome Mapping for Prediction of Alzheimer’s Disease
Amount Funded: $242,140.00
Development of a Clinically Integrated Prognostic Tool for Alzheimer’s Disease Using Deep Machine Learning Operating on a Connectome Network Diffusion Model
Amount Funded: $100,000.00
Development of a Novel, Quantitative MR Imaging Biomarker of Glymphatic Flow for Alzheimer’s Disease
Amount Funded: $99,952.00
MEG Spectral Analysis as a Biomarker in Alzheimer’s Disease
Amount Funded: $229,650.00
Developing an imaging biomarker for Alzheimer’s dementia based on vascular dysfunction
Amount Funded: $230,865.00
Multi-dimensional prediction of Alzheimer’s disease risk
Amount Funded: $230,426.00
High-Resolution Intracortical DTI for Early Detection of Alzheimer’s Disease
Amount Funded: $205,945.00
Multi-Shell HARDI/FOD and Structural MRI of White and Gray Matter Connectomics with Allopregnanolone Regenerative Therapy in MCI and Alzheimers Disease
Amount Funded: $100,000.00
Tau, amyloid and cerebral vascular health in people at risk for Alzheimer’s Disease
